Does Dr. BELISARIO ARANGO have financial conflicts of interest?

Dr. BELISARIO ARANGO (MD) has received a total of $196,509 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $196,509 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. BELISARIO ARANGO?

According to CMS Open Payments data, Dr. BELISARIO ARANGO received funding from DAIICHI SANKYO ($150,724), ASTRAZENECA PHARMACEUTICALS ($39,409), and GILEAD SCIENCES ($1,693).

Does Dr. BELISARIO ARANGO receive research grants or speaking fees?

Dr. BELISARIO ARANGO has received $196,509 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. BELISARIO ARANGO

MDReal-Time Hydrated

Specialty: Internal Medicine, Hematology & Oncology

Practice Location: OGDEN, UT 84405

NPI Number: 1295976827

LIFETIME INDUSTRY VALUE

$196,509

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ARANGO is a verified Internal Medicine, Hematology & Oncology practitioner based in OGDEN, UT.

Between 2021 and 2025, Dr. ARANGO had an overall industry promotional and research financial footprint of $196,509 as recorded in the federal CMS Open Payments database.

$196,509 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ARANGO's primary funding source is DAIICHI SANKYO, which accounts for $150,724 (representing 76.7% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

DAIICHI SANKYO

Rank 1

$150,724

76.7%

ASTRAZENECA PHARMACEUTICALS

Rank 2

$39,409

20.1%

GILEAD SCIENCES

Rank 3

$1,693

0.9%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.